
-
NYALA Digital Asset AG paves new way for digital securities as a profitable investment
-
Sweden's Mellberg fired as coach of MLS St. Louis City
-
Sabalenka steamrolls into French Open third round
-
Tiger's son Charlie Woods captures first junior crown
-
Russia proposes new Ukraine talks, Kyiv demands terms upfront
-
Agha and Hasan star in Pakistan's win over Bangladesh in first T20
-
Kenya's Ngugi wa Thiong'o, champion of African expression
-
French court jails ex-Syria rebel for 10 years for war crimes
-
Alcaraz, Swiatek and Sabalenka reach French Open third round
-
US firms plan to pass Trump tariff costs to consumers: Fed minutes
-
One missing as village largely destroyed in Swiss glacier collapse
-
'Inspired' Swiatek outclasses Raducanu at French Open
-
Foreign students wary of US as Trump presses 'dehumanizing' campaign
-
Former police chief 'scarred for life' 40 years after Heysel disaster
-
Trump says warned Netanyahu against striking Iran
-
In new battle, Rubio to refuse US visas over online 'censorship'
-
Russia says to give Ukraine peace terms at new talks in Istanbul
-
Alcaraz, Swiatek win at French Open as Sabalenka eyes third round
-
OPEC+ meets as oil output hike looms
-
Brazil breaks out in a rash over life-like doll craze
-
Alcaraz overcomes blip to reach French Open third round
-
Brazil airline Azul files for bankruptcy protection in US
-
In world first, Mexican voters to elect all judges
-
Musk 'disappointed' by Trump bill, in rare break with US president
-
Swiatek sweeps past Raducanu into French Open third round
-
Stocks sink as rally over eased trade tensions fades
-
Man Utd booed off after friendly loss in Malaysia
-
Telegram to get $300 mn in partnership with Musk's xAI
-
Chelsea and Real Betis fans clash before Conference League final
-
Czech FM summons Chinese ambassador over cyberattack
-
Palestinians in Gaza 'deserve more than survival,' says UN envoy
-
French surgeon sentenced to 20 years for abusing children
-
Longer flight delays without compensation? EU plan divides
-
Giro leader Del Toro hits back with stage 17 triumph
-
Ukrainian town mourns three siblings killed in Russian strike
-
'Like a rat race': Ruud limps out of French Open in second round
-
Village partially destroyed in Swiss glacier collapse
-
Alcaraz tested at French Open as Swiatek eyes third round
-
Toothless Man Utd beaten in Malaysia friendly
-
Rising Canada star Mboko credits family for keeping her grounded
-
Israel says killed Hamas's presumed leader in Gaza
-
US stocks rise, focus on Nvidia
-
Zheng feeling the love in Paris but wary of 'hungry' Mboko
-
Kremlin rebuffs Zelensky's call for meeting with Trump, Putin
-
UK records sunniest spring in over a century
-
French surgeon handed maximum term for abusing children for decades
-
Taiwan's Garland vows to keep the faith on Grand Slam debut
-
Paolini through as Swiatek, Alcaraz eye French Open third round
-
Kazakhstan to allow hunting once endangered antelopes
-
Political protests paralyse Bangladesh daily life
CMSC | -0.18% | 22.09 | $ | |
RBGPF | 3.9% | 65.56 | $ | |
RYCEF | 0.69% | 11.65 | $ | |
SCS | -2.04% | 10.29 | $ | |
RELX | -1.11% | 55.05 | $ | |
RIO | -1.42% | 59.95 | $ | |
GSK | -0.66% | 39.18 | $ | |
BCC | -3.24% | 86.73 | $ | |
NGG | -2.79% | 72.67 | $ | |
BCE | -1.51% | 21.16 | $ | |
JRI | -0.63% | 12.74 | $ | |
VOD | -1.06% | 10.39 | $ | |
BP | -0.73% | 28.94 | $ | |
CMSD | -0.36% | 22.05 | $ | |
AZN | -0.82% | 70.38 | $ | |
BTI | -0.38% | 45.09 | $ |

Indonesia approves first homegrown Covid-19 vaccine
Indonesia has approved its first locally developed Covid-19 vaccine for emergency use, the head of the country's public health agency said Friday, hailing it as a step toward "the nation's independence in access to medicine".
Jakarta has stressed the importance of developing national vaccines since the beginning of the pandemicbut it currently relies on China's Sinovac and the Western-made Moderna and Pfizer-BioNTech mRNA jabs.
The IndoVac jab, developed by state-owned pharmaceutical company Bio Farma and Texas-based Baylor College of Medicine, can now be used as a primary dose for an unvaccinated or partially vaccinated adult in the world's fourth most-populous country.
"The development... of a domestic vaccine is a pride for us Indonesians as a foundation and as the first step to achieve the nation's independence in access to medicine," head of the national food and drugs agency (BPOM) Penny Lukito said at a press conference Friday.
The medical chief said IndoVac had shown an efficacy rate of 92 percent, while there were no reports of death linked to it in trials and reported side effects were "generally mild".
A clinical study to use it as a booster jab is underway, Lukito said.
The agency also announced it had granted emergency use approval for an mRNA vaccine developed in China, becoming the first country to do so.
The inoculation developed by Walvax Biotechnology will be locally produced in Indonesia, the BPOM chief said.
The homegrown IndoVac jab has been granted a halal certificate, meaning it can be administered in line with the Islamic faith in Muslim-majority Indonesia.
Indonesia became the epicentre of Asia's Covid-19 pandemic in July last year as the Delta variant swept through the country.
Daily cases declined significantly by the end of the year but the spread of Omicron brought confirmed cases back to 30,000 a day.
It has since seen another sharp fall in case numbers andeliminated quarantine requirements for vaccinated travellers.
In total,Southeast Asia's largest economy has reported over 6.4 million confirmed cases with nearly 160,000 deaths.
Vaccination rollout has also been relatively slow compared to developed nations, with less than two-thirds of the population of 270 million receiving two jabs.
Y.Aukaiv--AMWN